The Estée Lauder Companies Inc. — Form 10-Q Summary
Business context and reporting period
The company manufactures and sells prestige beauty products across skin care, makeup, fragrance and hair care in more than 150 countries. This filing covers the quarter and nine months ended March 31, 2014, compared with the same periods in 2013. The request metadata says “2013 Q3,” but the filing is for fiscal 2014 third quarter.
Financial performance
- Third-quarter revenue: Net sales were $2,549.8 million, up 11% reported and 12% excluding currency effects. Prior-year sales included approximately $94 million of orders accelerated ahead of a systems rollout; excluding this comparison benefit, sales growth was 7%.
- Third-quarter earnings and margins: Gross profit was $2,051.1 million and gross margin was 80.4%, versus 80.7%. Operating income rose 39% to $341.6 million; operating margin was 13.4%, versus 10.7%. The company said operating income would have increased 6% and operating margin declined 10 basis points after adjusting for accelerated prior-year orders and restructuring adjustments. Net earnings attributable to the company increased 19% to $213.2 million; diluted EPS rose to $0.54 from $0.45.
- Nine-month results: Net sales increased 6% to $8,243.5 million (7% excluding currency effects). Operating income rose 5% to $1,447.4 million, while operating margin eased to 17.6% from 17.8%. Net earnings attributable to the company rose 2% to $946.4 million; diluted EPS was $2.40 versus $2.35.
- Category and regional trends: Third-quarter sales increased across all categories and regions. Skin care and makeup led category operating-income growth. For the nine months, fragrance operating income fell 27%, and Asia/Pacific operating income declined 3%, partly reflecting higher launch investment and weaker results in China, Hong Kong and Japan.
- Cash flow: Nine-month operating cash flow was $1,169.4 million, up from $934.2 million. Investing used $344.2 million, including $342.8 million of capital expenditures; financing used $744.7 million, including $600.3 million for treasury-stock purchases and $225.2 million of dividends paid. Cash increased $34.5 million to $1,530.2 million.
- Liquidity and debt: At March 31, cash was $1,530.2 million, current assets $4,691.8 million and current liabilities $2,039.3 million. Total debt was $1,346.1 million, mostly long-term; debt was 27% of total capitalization, down from 29% at June 30, 2013. No commercial paper or revolving-facility borrowings were outstanding. Management said cash, operating cash flow, credit availability and market access should support planned needs.
Material changes and unusual items
- A $38.3 million Venezuela remeasurement charge was recorded in SG&A, with no tax benefit. The company changed its bolivar remeasurement rate from 6.3 to the SICAD II rate of 49.81 after the mechanism became operational. It reported that Venezuela represented less than 1% of nine-month sales and about 2% of operating income before the charge.
- Third-quarter effective tax rate was 35.1%, compared with 23.0% a year earlier, largely because of prior-year tax benefits and a higher rate on foreign operations. The nine-month rates were 32.5% and 30.9%, respectively.
- The prior-year nine-month comparison included a $19.1 million debt-extinguishment expense and $23.1 million of other income, principally related to an amended Rodan + Fields sale agreement.
- The company repurchased approximately 8.7 million Class A shares for $600.3 million during the nine months and declared dividends totaling $0.58 per share. A further $10.9 million of repurchases occurred through April 25, 2014.
Outlook, commentary and risks
- Management continued its strategy of investing in product innovation, skin care, digital capabilities, emerging markets, travel retail and freestanding stores. It described overall performance as good but noted softness in certain European markets and Korea, an uncertain U.S. retail environment, currency pressure in some emerging markets, slower near-term China growth, and Chinese government actions affecting travel and spending.
- The final major wave of the Strategic Modernization Initiative was planned for July 2014. Management estimated that retailers might advance $125–$150 million of orders into fiscal 2014’s fourth quarter, with a diluted EPS impact of $0.14–$0.17. These are timing effects, not stated underlying growth guidance. The filing provides no broader quantified full-year earnings or sales guidance.
- Other stated risks include competitive pressure, retailer inventory and credit risks, foreign exchange volatility, consumer and channel shifts, product-launch execution, information-system implementation and security, and economic or political disruption. The company said its foreign currency cash-flow hedges were materially effective.
- In the Darphin dispute, the company had paid €25.3 million under a Paris court judgment, appealed the decision, and maintained an accrual below the judgment award; appeal arguments were scheduled for June 2014. Management said current litigation was not expected to have a material adverse effect, while noting outcomes could differ from its assessment.
Important facts for investors to verify
- Confirm the reporting period: the filing is fiscal 2014 Q3, despite the request metadata’s “2013 Q3.”
- Assess the sustainability of growth after removing the prior-year $94 million accelerated-order comparison and the expected fiscal 2014 Q4 SMI order timing effect.
- Track the impact of the Venezuela exchange-rate change, potential further currency controls, and the absence of a tax benefit on the remeasurement charge.
- Monitor margin trends, especially nine-month operating-margin compression, fragrance profitability and Asia/Pacific performance.
- Review cash conversion and capital allocation, including elevated inventory, capital expenditures, share repurchases and dividends.
- Follow the Darphin appeal and the company’s stated macroeconomic, currency, retail and systems-implementation risks.